Trial Profile
Functional Change and Efficacy of Duloxetine in Patients With Major Depression and Co-Morbid Soft Tissue Discomfort Symptoms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2020
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder; Musculoskeletal pain
- Focus Therapeutic Use
- 29 Dec 2009 New trial record